Brazil
Review Article
Brazilian Regulation in Pharmacovigilance: A Review
Author(s): Mastroianni PC, Varallo FR and Dagli-Hernandez CMastroianni PC, Varallo FR and Dagli-Hernandez C
Brazilian health legislation on drug surveillance has been available for only four decades. This study aimed to analyze the chronological evolution of the pharmacovigilance legislation in Brazil. A critical review of the legislations and communications published between 1976 and 2015 was conducted. Sixty-two (62) documents were identified. Advancements in the assessment of health technologies occurred only after the publication of the National Drug Policy (1998), the foundation of the National Health Surveillance Agency (ANVISA), and the creation of the National Center for Drug Monitoring (2001). From 2009,.. Read More»
DOI:
10.4172/2167-7689.1000164
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report